Equillium, Inc. (EQ)
Last updated: 2026-10-20 23:44:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Equillium, Inc. (EQ) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.39, with a market capitalization of $75.46M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.76 to $3.54. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$75.46M | |
$1.25 | |
$65.50 | |
$0.27 | |
$1.24 | |
702.21K | |
597.10K | |
-- | |
$3.54 | |
$0.76 | |
-- | |
-- |
Equillium, Inc. (EQ) After-Hours Stock Price
Equillium, Inc. (EQ) is trading at $1.39 in after-hours trading as of 2026-10-20 23:31:00, up 12.10% ($0.15) from the regular-session close of $1.24.
After-hours trading shows how investors are pricing EQ after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Equillium, Inc. (EQ) 7-Day Stock Price Change
Over the past seven days, Equillium, Inc. (EQ) moved from $1.41 to $1.39, representing a decline of 1.49% ($0.02).
The stock traded between $1.16 and $1.51 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 819.63 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
EQ 52-Week Price Position
Position in Range: 22.7%
EQ is currently trading at $1.39, placing it 22.7% of the way from its 52-week low of $0.76 to its 52-week high of $3.54. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Equillium, Inc. (EQ)?
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.
Equillium, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 14 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Equillium, Inc. (EQ) Stock on MEXC
Eligible investors can buy real shares of Equillium, Inc. (EQ) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Equillium, Inc. (EQ) stock price today?
2.Is EQ stock going up or down today?
3.What is EQ pre-market price?
4.What is EQ after-hours price?
5.Is EQ stock trading now?
6.Where does EQ sit relative to its 52-week high and low?
7.What sector is Equillium, Inc. in?
8.What is Equillium, Inc.'s market capitalization and where is it listed?
9.How is EQ valued in terms of P/E ratio and EPS?
10.Does Equillium, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
EQ Stock Calculator
Estimate the value between EQ shares and USD.
EQ Shares to USD
1.00 EQ shares = 1.389 USD
Calculations are estimates based on the latest available price and are for reference only.


